As lovastatin significantly enhanced in vivo antitumor efficacy of both AdE4 and AdE4-TRAIL, we tested if lovastatin would improve the in vitro killing effects of AdE4 and AdE4-TRAIL in PSA/PSMA-positive PCa cells. This evidence concerns the gene FOLH1 and posterior cortical atrophy.